February 2024

Welcome to our?Monthly Roundup.

In our February edition, we share the latest news, including:

• our new blog on objection handlers in navigating reimbursement
• our latest webinar recording on the European access environment for rare disease treatments
• impressions from the ACCESS 2024 conference
• insights from the UK BioIndustry Association (BIA) Parliamentary Reception

?We are thrilled to announce our collaboration with Genetic Alliance in honour of Rare Disease Day. Genetic Alliance campaign for timely diagnosis, better coordinated care, and improved screening, testing, services and treatment.?

We supported Genetic Alliance to develop a compelling infographic that aims to raise awareness about current access challenges in rare disease medicines and the challenges faced by patients and their families.

This collaboration brings together our expertise from our Health Technology Assessment (HTA) Tracker with Genetic Alliance's commitment to advancing health through the greater understanding of rare diseases. The Rare Disease Day infographic serves as a visual representation - shedding light on the importance of early diagnosis, proper medical management, and the significance of ongoing research in the field.

Mastering objection handlers is essential for driving success in market access activities within the pharma and MedTech industries.

Priscila Mazzola, Head of Value Communication, shares four essential tips for effective objection handlers in our latest blog.

Read the blog here

ACCESS 2024 International Annual Meeting & Expo

23 - 25 February 2024

Here are some impressions from ACCESS 2024 in Miami, where Brian Gavin and Brad Groves led a pre-conference short course on market access trends and opportunities in the European landscape.

Some of the key themes covered included:

1. Dynamic Trends: Explored the ever-evolving market access trends shaping the European landscape. From regulatory shifts to emerging technologies, staying ahead is crucial.
2. Collaborative Opportunities: Engaged in insightful discussions on fostering collaborations. Building strategic partnerships is pivotal for navigating complexities and optimising market access.
3. Patient-Centric Approaches: Explored the rising importance of patient-centric models. Understanding and addressing patient needs is integral to successful market access strategies.

Read more about the event here

UK BioIndustry Association (BIA) Parliamentary Reception?

Earlier this month, Nisha Tailor?and?Malcolm Boyd?from our Policy & Public Affairs team attended the UK?BioIndustry Association (BIA)?Parliamentary reception to listen to and join the conversations on improving patient access to treatments for rare diseases. ? Ahead of Rare Disease Day 2024, we want to continue to raise awareness of the 7,000 known rare diseases and whilst individually these diseases are rare, collectively they are estimated to affect over 3.5m individuals in the UK. Not only do these diseases impact patients directly, but they often place a significant burden on patients’ families and carers. For 95% of rare diseases, there is no approved treatment.

Read the latest BIA report on 'Evaluating patient access to rare disease treatments' here

Breaking down barriers to access in Europe - getting it right first time for rare diseases!?

Wednesday 21 February 2024

Thank you to all who joined us for this month's webinar on breaking down barriers to access in Europe - getting it right first time for rare diseases! Thanks to our speakers,?Simon Pannett,?Jo Wallis,?Brad Groves?and?Helen Landels for providing their insights and expertise. We'd recommend viewing this session if you are a global or European product innovator, market access, pricing and reimbursement professionals who would like to unlock the opportunities available for revenue optimisation in Europe.? If you missed it and would like to request the recording of the webinar, you can do so using the button below.

Request the webinar recording here

If you would like to contact us on any of the topics above, please do get in touch with us at [email protected] – we would love to hear from you.

Best wishes,

The MAP Team